17-41149607-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_033188.4(KRTAP4-5):c.161C>A(p.Thr54Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,610,978 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_033188.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KRTAP4-5 | NM_033188.4 | c.161C>A | p.Thr54Asn | missense_variant | 1/1 | ENST00000343246.6 | NP_149445.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KRTAP4-5 | ENST00000343246.6 | c.161C>A | p.Thr54Asn | missense_variant | 1/1 | 6 | NM_033188.4 | ENSP00000340546.4 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151326Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000843 AC: 21AN: 249150Hom.: 0 AF XY: 0.0000887 AC XY: 12AN XY: 135248
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1459652Hom.: 0 Cov.: 146 AF XY: 0.0000234 AC XY: 17AN XY: 726178
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151326Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73860
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 17, 2024 | The c.161C>A (p.T54N) alteration is located in exon 1 (coding exon 1) of the KRTAP4-5 gene. This alteration results from a C to A substitution at nucleotide position 161, causing the threonine (T) at amino acid position 54 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at